Treatment outcome of multi-drug resistant tuberculosis in the Republic of Moldova

V. Vilc (Chisinau, Republic of Moldova)

Source: International Congress 2017 – TB: co-morbidities and outcome
Session: TB: co-morbidities and outcome
Session type: Thematic Poster
Number: 2730
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Vilc (Chisinau, Republic of Moldova). Treatment outcome of multi-drug resistant tuberculosis in the Republic of Moldova. 2730

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Treatment outcome of multi-drug resistant tuberculosis in Varanasi, India
Source: Eur Respir J 2002; 20: Suppl. 38, 615s
Year: 2002

Frequency of multi-drug resistant M.tuberculosis and HLA-class-2 gene associations in tuberculosis patients in the Republic of Tuva
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis I
Year: 2008


Treatment of multidrug resistant tuberculosis in penitentiary system of Tomsk Oblast
Source: Eur Respir J 2001; 18: Suppl. 33, 338s
Year: 2001

High-dose isoniazid in the shorter-course multidrug-resistant tuberculosis regimen in the Republic of Moldova
Source: Eur Respir J, 50 (4) 1701340; 10.1183/13993003.01340-2017
Year: 2017



Genetic markers of multi-drug and extensive drug resistant M. tuberculosis in Kyrgyz Republic
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools
Year: 2012

Prevalence of aminoglycoside resistance among different MDR tuberculosis cases in Ukraine
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013


Multidrug-resistant and extensively drug resistance tuberculosis has a strong public health and economical impact in the Republic of Moldova
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013

Primary and secondary drug-resistance of M. tuberculosis to rifampicin in Kyrgyz Republic
Source: Eur Respir J 2005; 26: Suppl. 49, 199s
Year: 2005

Characteristics and treatment outcome of MDR-TB in the Czech Republic
Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis
Year: 2010


Treatment outcome in patients with MDR-TB treated with bedaquiline containing regimens, Republic of Moldova
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020


Prevalence of fluoroquinolon-resistance among different MDR tuberculosis cases in Ukraine
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013


Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia
Source: Eur Respir J 2012; 40: 133-142
Year: 2012



Trend in TB control in Republic of Moldova: High MDRTB burden country
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014

Nationwide anti-tuberculosis drug resistance survey in the Republic of Azerbaijan
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014


Dynamics of drug-resistant tuberculosis in Tatarstan Republic
Source: Eur Respir J 2001; 18: Suppl. 33, 513s
Year: 2001

Prevalence of drug resistance tuberculosis in the Republic of Moldova during the 1995-2005
Source: Eur Respir J 2007; 30: Suppl. 51, 700s
Year: 2007

Drug resistant tuberculosis in Odessa, Southern Ukraine: Beijing family strains prevalence and the role of prisons in drug resistant TB transmission
Source: Eur Respir J 2006; 28: Suppl. 50, 290s
Year: 2006

Multidrug resistant tuberculosis (MDR – TB) treatment outcomes in Iran
Source: Eur Respir J 2004; 24: Suppl. 48, 657s
Year: 2004

Outcome of multi-drug resistant tuberculosis in Belgrade
Source: Eur Respir J 2001; 18: Suppl. 33, 312s
Year: 2001

High risk and rapid appearance of multidrug resistance during tuberculosis treatment in Moldova
Source: Eur Respir J 2014; 43: 1132-1141
Year: 2014